The Brain Buzz
BrainFx Partners with Physical FCE platform
We're proud to announce our partnership with Metriks Education Inc. BrainFx and Metriks Education Inc. announce a strategic partnership to advance the cognitive and physical measurement of human performance. BrainFx and Metriks today announce the availability of a...
BrainFx among the Top 200 NeuroTech companies in the world
“Global NeuroTech Industry Landscape Overview 2020” delivers comprehensive market mapping and landscape analysis to identify the key players in NeuroTech… “...(the industry) is one of the most promising and prospective sectors of modern BioTech in particular and...
One of the most advanced tests for cannabis impairment is being developed in Toronto
We’ve been working with a group of world-class partners Toronto Rehabilitation Institute & Apollo Applied Research Inc to develop an advanced cognitive screen to assist in the detection of cannabis impairment. Neil Vorano spoke with CEO Tracy Milner to discuss the...
Anthony Lacavera discusses cognitive assessments with BrainFx CEO Tracy Milner
BrainFx CEO & Co- founder Tracy Milner sits down with Globalive Media‘s Anthony Lacavera (interview supported by iGan Partners) to discuss BrainFx assessments and it’s applications with those facing brain disorders such as dementia and Alzheimer's disease. As...
The Early Science of Brain Health
In reflecting on the magnitude of research and clinical activities that brain health includes, I am humbled by all the contributions that are being made to neuroscience. Neuroscience is still very young, with so much to explore and understand. It is for this reason...
Detection Invites Prevention: Saint Elizabeth Health partners with BrainFx
Partnership in Research BrainFx is proud of its partnership with Saint Elizabeth Health, participating Ontario Family Health Teams, and Wilfrid Laurier University on a research study focused on evaluating BrainFx’s SCREEN with Ontario’s age 55+ population. Together...
Our latest research
Working with the Mayo Clinic to understand Long-COVID
This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researches to better understand and address the impacts of this new and emerging phenomena.
Interested in working with us?
Get in touch with us below to learn more
Let's make the INVISIBLE effects of brain disorders VISIBLE, together.
Copyright © 2022 - BrainFx. All rights reserved.
Important Information: BrainFx Assessments only provide information about neurofunctional performance. Assessment results detail the patient/client's performance on assessment activities completed and only assist the health care team in identifying potential areas of strength or challenge as related to function. Assessments DO NOT provide any diagnosis or treatment recommendations. BrainFx Assessments are only permitted to be delivered by trained clinicians. Assessment reports are not stand-alone and require the interpretation of a health professional within their scope of practice and in the context of all information that they have gathered about their patient/client. In Canada, BrainFx Assessments are cleared by Health Canada as a Class 1 Software as a Medical Device. BrainFx Assessments and the statements made on this website have not been evaluated by any other regulatory bodies. Assessments are not intended to diagnose, treat, cure, or prevent any disease. Information provided by BrainFx is not a substitute for face-to-face consultation with your health care professional and should not be construed as individual medical advice.